5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications.

作者: Enzo Lalli , Hironobu Sasano

DOI: 10.1007/S12672-015-0240-3

关键词:

摘要: Groundbreaking progress has been recently made in elucidating the signaling pathways that are altered adrenocortical carcinoma (ACC), an endocrine malignancy still unfavorable prognosis, and understanding its genomic structure. These advances need now to be translated create cellular animal models more relevant human disease order develop new effective diagnostic procedures targeted therapies against this deadly malignancy.

参考文章(47)
Lalli E, de Oliveira Bh, Maluf Df, Therapy of adrenocortical cancer: present and future. American Journal of Cancer Research. ,vol. 1, pp. 222- 232 ,(2011)
Aude Salomon, Michelle Keramidas, Cécile Maisin, Michaël Thomas, Loss of β-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition Oncotarget. ,vol. 6, pp. 11421- 11433 ,(2015) , 10.18632/ONCOTARGET.3222
S G Creemers, L J Hofland, E Korpershoek, G J H Franssen, F J van Kemenade, W W de Herder, R A Feelders, Future directions in the diagnosis and medical treatment of adrenocortical carcinoma Endocrine-related Cancer. ,vol. 23, ,(2016) , 10.1530/ERC-15-0452
T. M. A. Kerkhofs, M. N. Kerstens, I. P. Kema, T. P. Willems, H. R. Haak, Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal Tumors Hormones and Cancer. ,vol. 6, pp. 168- 175 ,(2015) , 10.1007/S12672-015-0224-3
Xuyu Cai, Filip Janku, Qimin Zhan, Jian-Bing Fan, Accessing Genetic Information with Liquid Biopsies. Trends in Genetics. ,vol. 31, pp. 564- 575 ,(2015) , 10.1016/J.TIG.2015.06.001
Anthony R. Glover, Jing Ting Zhao, Anthony J. Gill, Jocelyn Weiss, Nancy Mugridge, Edward Kim, Alex L. Feeney, Julian C. Ip, Glen Reid, Stephen Clarke, Patsy S.H. Soon, Bruce G. Robinson, Himanshu Brahmbhatt, Jennifer A. MacDiarmid, Stan B. Sidhu, microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma Oncotarget. ,vol. 6, pp. 36675- 36688 ,(2015) , 10.18632/ONCOTARGET.5383
Diana Rita Szabó, Michaela Luconi, Peter M Szabó, Miklós Tóth, Nikolette Szücs, János Horányi, Zoltán Nagy, Massimo Mannelli, Attila Patócs, Károly Rácz, Peter Igaz, Analysis of circulating microRNAs in adrenocortical tumors Laboratory Investigation. ,vol. 94, pp. 331- 339 ,(2014) , 10.1038/LABINVEST.2013.148
Armelle Logié, Philippe Boudou, Liliane Boccon-Gibod, Eric Baudin, Gilles Vassal, Martin Schlumberger, Yves Le Bouc, Christine Gicquel, Establishment and characterization of a human adrenocortical carcinoma xenograft model. Endocrinology. ,vol. 141, pp. 3165- 3171 ,(2000) , 10.1210/ENDO.141.9.7668
Martin Fassnacht, Massimo Terzolo, Bruno Allolio, Eric Baudin, Harm Haak, Alfredo Berruti, Staffan Welin, Carmen Schade-Brittinger, André Lacroix, Barbara Jarzab, Halfdan Sorbye, David J Torpy, Vinzenz Stepan, David E Schteingart, Wiebke Arlt, Matthias Kroiss, Sophie Leboulleux, Paola Sperone, Anders Sundin, Ilse Hermsen, Stefanie Hahner, Holger S Willenberg, Antoine Tabarin, Marcus Quinkler, Christelle De La Fouchardière, Martin Schlumberger, Franco Mantero, Dirk Weismann, Felix Beuschlein, Hans Gelderblom, Hanneke Wilmink, Monica Sender, Maureen Edgerly, Werner Kenn, Tito Fojo, Hans-Helge Müller, Britt Skogseid, None, Combination Chemotherapy in Advanced Adrenocortical Carcinoma The New England Journal of Medicine. ,vol. 366, pp. 2189- 2197 ,(2012) , 10.1056/NEJMOA1200966
Victoria M. Raymond, Tobias Else, Jessica N. Everett, Jessica M. Long, Stephen B. Gruber, Gary D. Hammer, Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma. The Journal of Clinical Endocrinology and Metabolism. ,vol. 98, ,(2013) , 10.1210/JC.2012-2198